Bergman: ‘The time is now’ to push for breakthroughs in psychedelic treatments
Healthcare Bergman: ‘The time is now’ to push for breakthroughs in psychedelic treatments Comments: by Joseph Choi - 05/19/26 12:43 PM ET Comments: Link copied by Joseph Choi - 05/19/26 12:43 PM ET Comments: Link copied NOW PLAYING Rep. Jack Bergman (R-Mich.) said on Tuesday that “the time is now” to push for breakthroughs in psychedelic treatments given President Trump’s recent support for this field of research. Trump signed an executive order aimed at accelerating psychedelic drugs used to treat mental health disorders.
- ▪Healthcare Bergman: ‘The time is now’ to push for breakthroughs in psychedelic treatments Comments: by Joseph Choi - 05/19/26 12:43 PM ET Comments: Link copied by Joseph Choi - 05/19/26 12:43 PM ET Comments: Link copied NOW PLAYING Rep.
- ▪Jack Bergman (R-Mich.) said on Tuesday that “the time is now” to push for breakthroughs in psychedelic treatments given President Trump’s recent support for this field of research.
- ▪Trump signed an executive order aimed at accelerating psychedelic drugs used to treat mental health disorders.
Opening excerpt (first ~120 words) tap to expand
Healthcare Bergman: ‘The time is now’ to push for breakthroughs in psychedelic treatments Comments: by Joseph Choi - 05/19/26 12:43 PM ET Comments: Link copied by Joseph Choi - 05/19/26 12:43 PM ET Comments: Link copied NOW PLAYING Rep. Jack Bergman (R-Mich.) said on Tuesday that “the time is now” to push for breakthroughs in psychedelic treatments given President Trump’s recent support for this field of research. At The Hill’s “Rethinking Psychedelic Treatment for America’s Mental Health Crisis” event sponsored by Definium Therapeutics, Bergman, co-founder and co-chair of Congressional Psychedelics Advancing Therapies (PATH) Caucus, said he was “excited” that an executive order issued last month is encouraging more people to take the “risk” in researching psychedelic drugs.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hill.